Taken together, our study of the NFκB signalling pathway in the experimental PD model in comparison with bioinformatics analysis of SARS-CoV-2, supports the notion that activation of the NFκB signalling cascade may be a common inflammatory pathway observed in the pathogenesis of both PD and COVID-19. Here, NFKB1 is linked to COVID-19.